Presentations and Postersby Voluntary Organization JBCRG
2004
Cyclophosphamide, epirubicin, and fluorouracil followed by docetaxel (CEF – DOC) as preoperative chemotherapy in primary operable breast cancer.
Kuroi K, Toi M, Takatsuka Y, Iwata H, Ohno S, Kusama M, Shin E, Hisamatsu K, Yamazaki K, Sato Y, Masuda N, Kaise H, Akiyama F, Nakamura S; Japan Breast Cancer Research Group (JBCRG)
15th International Congress on Anti Cancer Treatment, Paris (France), Feb. 2004
Cyclophosphamide, epirubicin, and fluorouracil followed by docetaxel (CEF – DOC) as preoperative chemotherapy in primary operable breast cancer.
Nakamura S, Ohno S, Toi M, Takatsuka Y, Kuroi K, Iwata H, Hisamatsu K, Yamazaki K, Masuda N, Akiyama F; Japan Breast Cancer Research Group (JBCRG)
2004 American Society of Clinical Oncology, New Orleans (USA), Jun. 2004
The effect of Pathological Response of Multicenter phase II trial of sequential FEC followed by docetaxel in primary operable breast cancer – interim analysis –
Ohno S, Toi M, Kuroi K, Nakamura S, Iwata H, Kusama M, Masuda N, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Akiyama F; Japan Breast Cancer Research Group (JBCRG).
27th San Antonio Breast Cancer Symposium, Poster, SanAntonio (USA), Dec. 2004